SCHEMBL12724481

SCHEMBL12724481

CNc1ccc(NC(=O)c2ccc(C(c3ccc(C(C)=O)cc3)(C(F)(F)F)C(F)(F)F)cc2)c(C(O)(C(F)(F)F)C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
MEN1 O00255 3/20 0.46
MAPK1 P28482 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RORC P51449 1/20 0.44
RXFP1 Q9HBX9 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
RAB9A P51151 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
XBP1 P17861 2/20 0.39
KCNJ11 Q14654 3/20 0.38
POLB P06746 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724479 0.94 KMT2A (0.48) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL13970950 0.88 RORC (0.42) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL13294572 0.85 MAPK1 (0.48) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL13224236 0.84 KMT2A (0.44) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL676652 0.83 HDAC1 (0.46) KMT2AMEN1RORCRXFP1AKR1C3
SCHEMBL12724499 0.81 MEN1 (0.41) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL13294569 0.79 MEN1 (0.50) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL12724502 0.76 MEN1 (0.41) KMT2AMEN1MAPK1ALOX15TSHR
SCHEMBL25534791 0.76 PRKCI (0.55) MAPK1RXFP1RAB9AMAPTHDAC3
SCHEMBL15745812 0.76 MEN1 (0.39) KMT2AMEN1MAPK1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932348-B2 Fluorine-containing polymerizable monomer and polymer compound using same CENTRAL GLASS COMPANY, LIMITED (JP) 2011-04-26 US disclosed
US-7825280-B2 Fluorine-containing polymerizable monomer and polymer compound using same CENTRAL GLASS COMPANY, LIMITED (JP) 2010-11-02 US disclosed
US-20100234556-A1 Fluorine-Containing Polymerizable Monomer and Polymer Compound Using Same CENTRAL GLASS COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-20090023886-A1 Waterproofing; oil repellents; heat resistance; weatherproofing; corrosion resistance; radiation transparent; photosensitivity; low refractive index, dielectrics CENTRAL GLASS COMPANY, LIMITED (JP) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023886-A1 Waterproofing; oil repellents; heat resistance; weatherproofing; corrosion resistance; radiation transparent; photosensitivity; low refractive index, dielectrics PFN1, PFAS, FRG1 KMT2A 3027/4885MEN1 878/4885MAPK1 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.